In-depth clinical reviews for physicians and healthcare professionals. Each title; including diagnostic criteria, doses, gestational age thresholds and timing of birth—with extensive references from ACOG, RCOG, NICE, SMFM, Cochrane and UpToDate.
⚕️ Target audience: These reviews are intended for physicians and healthcare professionals; It is a summary of current literature and guidelines for educational purposes. Clinical decisions should be made based on patient-specific evaluation and applicable institutional protocols.
Hypothyroidism and hyperthyroidism on one page: TSH thresholds, levothyroxine dose escalation, PTU–methimazole selection, TRAb-based fetal monitoring, thyroid storm and postpartum thyroiditis.
Diagnostic methods based on history, ultrasound and physical examination; thresholds and pitfalls of cervical length measurement; The evidence base for the choice between vaginal progesterone and cerclage.
PPH management from cumulative blood loss threshold to uterotonic doses, from the first three hour rule of tranexamic acid to massive transfusion targets.
Differentiation of normal course and warning signs in puerperium, timing of follow-up, mental health and cardiometabolic screening, choice of contraceptive method in breastfeeding women.
PROM management, from the false positive problem of biomarker tests to latency antibiotic regimens and the 34–37 week birth timing debate.
Timing and success determinants of ECV in term breech presentation, evidence base for the decision on mode of delivery, and criteria and technique of vaginal breech delivery in selected cases.
Summary of background risk, critical developmental windows, removal of FDA letter categories, pharmacokinetics in pregnancy, and commonly used drug groups.
Guideline-based summary of vertical transmission rates, where screening decisions differ by institution, prenatal diagnosis timing, and treatment thresholds.
CRL 7 mm and sac 25 mm thresholds, waiting–medication–surgery comparison, institution differentiation in anti-D decision, and recurrent pregnancy loss workup panel.
From diagnostic criteria and hCG elevation rate to methotrexate protocols, from the choice of salpingostomy–salpingectomy to interstitial and cesarean scar pregnancy.
Guideline-based management of induction, from cervical ripening doses to oxytocin regimens, from the ARRIVE discussion to the decision to induce at 41 weeks.
Summary of AFI and SDP thresholds, impact of measurement method on induction rate, etiology, amnioreduction, and birth timing decisions.
Classification and diagnostic criteria, sFlt-1/PlGF pathophysiology, low-dose aspirin prophylaxis, MgSO4 seizure prophylaxis, acute antihypertensives and timing of birth.
One-step 75g and two-step 50g/100g screening, diagnostic thresholds, glycemic targets, insulin and oral agents, fetal monitoring and postpartum screening.
36 0/7–37 6/7 weeks screening, intrapartum antibiotic indications, penicillin regimens and penicillin allergy algorithm.
Trimester-based hemoglobin thresholds, differential diagnosis, oral and intravenous iron therapy, ferritin threshold and transfusion indications.
Hypercoagulability in pregnancy, RCOG risk scoring, LMWH doses, mechanical prophylaxis and timing of neuraxial anesthesia.
Delphi consensus definition, etiology, Doppler assessment (umbilical/MCA/CPR/ductus venosus), and timing of birth according to Doppler finding.
Cervical length/fFN, vaginal progesterone and cerclage, antenatal corticosteroids, MgSO4 neuroprotection and tocolytic selection.
Screening, event-based anti-D Ig doses and timing, MCA-PSV monitoring in sensitized pregnancy, and fetal RHD genotyping.
Safely reducing primary cesarean section, TOLAC candidate selection, prediction of success, risk of uterine rupture, and placenta accreta spectrum.
Initial visit panel, visit schedule (traditional/telehealth), aneuploidy screening (cfDNA/NIPT), anomaly screening, and routine testing schedule.
Combined first-trimester (CFTS), quadruple, and NIPT/cfDNA performance, side-by-side guideline comparison, GRADE certainty table, and invasive confirmation algorithm for abnormal results.
Current guideline-based management of ICP with bile acid thresholds, risk of stillbirth, discussion of UDCA, and timing of birth.
Windsor diagnostic criteria, GDF15 axis, stepwise antiemetic therapy and doses (ACOG PB 189; RCOG GTG 69, 2024).
Risk stratification, USG diagnostic thresholds, timing of birth and principles of cesarean hysterectomy in Previa and PAS.
Chorionicity, TTTS-TAPS-FGR management, and timing of delivery in twin/triplet pregnancy—ACOG, ISUOG, SMFM guidelines.
Last updated: . In each clinical review, subject-specific full reference citations (guide number/year, PMID/DOI) are also stated.